8 clinical trials found.
-
A Phase 2/3 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis
The purpose of this study is to measure clinical safety and efficacy of oral brepocitinib in adult participants with cutaneous sarcoidosis.- Study details include:
- Up ...
Phase
TRIAL ROLE: Principal Investigator
-
A single-center observational study of the natural history and pathogenesis of hidradenitis suppurativa
A single-center observational study of the natural history and pathogenesis of hidradenitis suppurativaPhase N/A TRIAL ROLE: Sub Investigator
-
THE ROLE OF THE MICROBIOME IN MONOZYGOTIC TWINS WITH PSORIASIS AND PSORIATIC ARTHRITIS
We propose a longitudinal study of monozygotic twins discordant for psoriatic disease. Subjects will be characterized with detailed clinical questionnaires in addition to blood, fecal ...Phase N/A
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Psoriatic Response and Onset: Genes Radiology Environment Skin and Synovium)
This is a longitudinal, observational cohort study to aimed to understand the clinical and biologic underpinnings of psoriasis and psoriatic arthritis development and severity. To ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Lupus Omics Cutaneous Kidney Investigative Team: Skin Project 1 and Skin Project 2
Cutaneous lupus erythematosus (CLE) includes three main subsets: acute CLE (ACLE), subacute CLE (SCLE) and chronic CLE (CCLE), the latter including discoid lupus erythematosus (DLE ...Phase N/A TRIAL ROLE: Co-Investigator
-
Autoimmune and Autoinflammatory Genetics Study
This is an exploratory natural history protocol that will enroll patients with known or as yet undiagnosed disorders of inflammation. Blood, saliva, hair, nail, or ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
The goal of Accelerating Medicines Partnership (AMP) is to better understand and develop new treatments for autoimmune disorders (such as Psoriatic Spectrum Disease (PSD)), and ...Phase N/A TRIAL ROLE: Sub Investigator
-
Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Disease (AIM) Rheumatoid Arthritis
The goal of AMP is to develop new treatments for autoimmune disorders (such as RA), and to reduce the time and cost of developing these ...Phase N/A TRIAL ROLE: Sub Investigator
